Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vulvar Atrophy”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Not applicableLooking for participantsNCT05890092
What this trial is testing

Vulvar Disease in Nigeria Observational Study

Who this might be right for
Vulvar DiseasesVulvar AtrophyDermatoses
KDRS ltd 1,000
Not applicableStudy completedNCT04148651
What this trial is testing

The CO2RE® System for Vulvar Lichen Sclerosus

Who this might be right for
Vulvar Lichen Sclerosus
Candela Corporation 14
Large-scale testing (Phase 3)Study completedNCT00238732
What this trial is testing

Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Vasomotor Symptoms Associated With Menopause

Who this might be right for
Vaginal Atrophy
Wyeth is now a wholly owned subsidiary of Pfizer 650
Testing effectiveness (Phase 2)Study completedNCT00630539
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women

Who this might be right for
AtrophyVaginal Diseases
Shionogi 126
Large-scale testing (Phase 3)Study completedNCT02253173
What this trial is testing

Estradiol Vaginal Softgel Capsules in Treating Symptoms of Vulvar and Vaginal Atrophy in Postmenopausal Women

Who this might be right for
Vulvovaginal AtrophyMenopauseDyspareunia+1 more
TherapeuticsMD 764
Not applicableStudy completedNCT02937805
What this trial is testing

Effects of a Moisturizing Cream on Vaginal and Vulvar Mucous Membranes

Who this might be right for
Vaginal DrynessVaginal AtrophyVulvar Dryness+1 more
Petra Larmo 225
Post-approval studies (Phase 4)Study completedNCT02784613
What this trial is testing

Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA

Who this might be right for
Vulvovaginal AtrophyDyspareunia
Sue Goldstein 10
Not applicableLooking for participantsNCT04042766
What this trial is testing

Laser Vaginal Treatment for GSM

Who this might be right for
Menopausal Urethral AtrophyVulvar Atrophy
Sunnybrook Health Sciences Centre 60
Not applicableActive Not RecruitingNCT05631665
What this trial is testing

Genital Laser Treatment in Postmenopausal Patients

Who this might be right for
DyspareuniaMenopauseSexual Activity+1 more
Kanuni Sultan Suleyman Training and Research Hospital 1
Large-scale testing (Phase 3)Study completedNCT01586364
What this trial is testing

Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus

Who this might be right for
AtrophyVaginal Diseases
Shionogi 301
Large-scale testing (Phase 3)Study completedNCT00276094
What this trial is testing

A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

Who this might be right for
AtrophyVaginal Diseases
Shionogi 826
Large-scale testing (Phase 3)Study completedNCT01585558
What this trial is testing

Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus

Who this might be right for
AtrophyVaginal Diseases
Shionogi 180
Not applicableEnded earlyNCT04297319
What this trial is testing

The Use of Laser in the Treatment of Atrophic Vulvovaginitis

Who this might be right for
LasersAtrophy of VaginaAtrophy Vulva
Hospital Italiano de Buenos Aires 20
Not applicableStudy completedNCT04147689
What this trial is testing

Evaluation of the Efficacy and Safety of Hyaluronic Acid Injection in Labia Majora for Volume Restoration

Who this might be right for
Vulvar Atrophy
Laboratoires Vivacy 72
Testing effectiveness (Phase 2)UnknownNCT00453089
What this trial is testing

VG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal Women

Who this might be right for
Vaginal AtrophyVulvar Atrophy
Bionovo 40
Testing effectiveness (Phase 2)WithdrawnNCT04159493
What this trial is testing

Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy

Who this might be right for
Vaginal Atrophy
Aspen USA Inc
Not applicableLooking for participantsNCT06203106
What this trial is testing

NYSCF Scientific Discovery Biobank

Who this might be right for
ALSAmyotrophic Lateral SclerosisAlzheimer Disease+26 more
New York Stem Cell Foundation Research Institute 10,000
Post-approval studies (Phase 4)Study completedNCT04705883
What this trial is testing

Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors

Who this might be right for
Vulvar AtrophyBreast CancerGenitourinary Syndrome of Menopause
Hospital Clinic of Barcelona 10
Testing effectiveness (Phase 2)Study completedNCT05378269
What this trial is testing

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA

Who this might be right for
Vulvar Atrophy
Daré Bioscience, Inc. 17
Large-scale testing (Phase 3)Study completedNCT01256671
What this trial is testing

DHEA Against Vaginal Atrophy - Safety Study of 12 Months

Who this might be right for
Vaginal Atrophy
EndoCeutics Inc. 530
Load More Results